These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22690340)

  • 1. Circulating tumor cells measurements in hepatocellular carcinoma.
    Chiappini F
    Int J Hepatol; 2012; 2012():684802. PubMed ID: 22690340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives.
    Zhang Y; Li J; Cao L; Xu W; Yin Z
    Semin Oncol; 2012 Aug; 39(4):449-60. PubMed ID: 22846862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
    Front Oncol; 2021; 11():734564. PubMed ID: 34722281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells (CTC) detection: clinical impact and future directions.
    Paterlini-Brechot P; Benali NL
    Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
    Cui K; Ou Y; Shen Y; Li S; Sun Z
    Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
    Front Oncol; 2020; 10():1758. PubMed ID: 33224869
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Chen Z; Lin X; Chen C; Chen Y; Zhao Q; Wu L; Wang D; Ma Y; Ju W; Chen M; He X
    Ann Transl Med; 2020 Sep; 8(17):1067. PubMed ID: 33145286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cell detection on its way to routine diagnostic implementation?
    Sleijfer S; Gratama JW; Sieuwerts AM; Kraan J; Martens JW; Foekens JA
    Eur J Cancer; 2007 Dec; 43(18):2645-50. PubMed ID: 17977713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma.
    Chen Y; Li S; Li W; Yang R; Zhang X; Ye Y; Yu J; Ye L; Tang W
    Sci Rep; 2019 May; 9(1):7084. PubMed ID: 31068623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.
    Yu JJ; Xiao W; Dong SL; Liang HF; Zhang ZW; Zhang BX; Huang ZY; Chen YF; Zhang WG; Luo HP; Chen Q; Chen XP
    BMC Cancer; 2018 Aug; 18(1):835. PubMed ID: 30126375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma.
    Zhou KQ; Sun YF; Cheng JW; Du M; Ji Y; Wang PX; Hu B; Guo W; Gao Y; Yin Y; Huang JF; Zhou J; Fan J; Yang XR
    EBioMedicine; 2020 Dec; 62():103107. PubMed ID: 33181461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.